NYSE$SOLV

Solventum Corporation · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Briefing

Solventum reported Q3 2025, revenue of $2.01B, net income of $126M, diluted EPS of $0.72.

For Q3 2025, Solventum reported revenue of $2.01B, net income of $126M, diluted EPS was $0.72. The filing discusses segment trends, liquidity, and management outlook for upcoming periods.

  • Revenue $2.01B.
  • Net income $126M.
  • Diluted EPS $0.72.

Headline financials

Total Revenue

$2.1B

Previous: $2.08B+0.7%
EPS (adj)

$0.72

Previous: $0.70+2.9%
Capital Expenditures

-$316M

Previous: -$253M-24.9%
Free Cash Flow

-$22M

Previous: -$131M+83.2%
Net Income

$1.27B

Previous: $122M+937.7%
Operating Income

$1.69B

Previous: $275M+514.5%
Gross Profit

$1.14B

Previous: $1.17B-2.6%

Revenue & EPS history

Solventum · Revenue · Quarterly

$2.1B

Q3 2025+0.7%vs Q3 2024
Beat estimate in 6 of 10 quarters(60%)
ActualEstimate

Revenue by segment

Solventum · $1.83B total across 3 segments · Q3 2023

  • MedSurg
    $1.18B
  • Dental Solutions
    $331M
  • Health Information Systems
    $321M

Forward guidance

The release discusses Solventum's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed.

Tailwinds

  • Solventum cites demand and execution supporting the near-term outlook.
  • Liquidity and balance-sheet capacity support operations and shareholder returns.

Headwinds

  • Macro, input costs, and FX may pressure margins quarter to quarter.
  • Segment mix and one-time items can affect comparability versus prior periods.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+0.2%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+2.1%

Avg return

30 days after

42%

5 / 12 earnings

Positive

+8.4%

Q2 2024

Best reaction

-4.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.4%+8.7%+21.2%
Q4 2025-3.7%-8.5%-18.4%
Q3 2025+7.7%+11.4%+28.9%
Q2 2025+1.7%+3.4%+1.1%
Q1 2025+5.5%+6.8%+12.3%
Q4 2024-4.4%-6.7%-10.4%
Q3 2023-4.7%-6.7%-6.8%
Q3 2024-2.3%-4.6%-5.6%
Q2 2023-1.6%-1.5%+12.9%
Q2 2024+8.4%+4.2%+18.4%
Q1 2023-2.6%-3.7%-13.0%
Q1 2024-4.0%-2.0%-15.1%
Q4 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro